Related Experiment Video
Updated: Sep 9, 2025

Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay
Published on: June 16, 2023
Use of Procalcitonin for Detection of Bacterial Infection in Patients With Chronic Kidney Disease: A Retrospective
Onder Sabahat1, Aylia Yesilova2, Namigar Turgut3
1Department of Internal Medicine, Hisar Intercontinental Hospital, Istanbul, Turkey.
Aim:
Procalcitonin (PCT) interpretation in chronic kidney disease (CKD) patients is challenging, as levels may rise even without infections. This study aimed to evaluate PCT dynamics during bacterial infections across CKD stages and assess its diagnostic utility.
Material And Methods:
In this retrospective, single-center study, 505 hospitalized patients (293 with CKD and 212 controls) with confirmed bacterial infections were included. Patients were classified according to KDIGO CKD stages. PCT levels were measured at 24, 48, 72, 96 h, and at discharge.
Results:
PCT levels were significantly higher in CKD patients compared to those without CKD at all time points. Levels tended to increase or remain elevated with advancing CKD stage, except in stage 5. A significant decline in PCT was observed at the 96th hour, with a delayed decrease in advanced CKD.
Conclusion:
PCT is a valuable biomarker for bacterial infections in CKD; however, stage-specific thresholds may be necessary to avoid misdiagnosis and improve clinical utility.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Pyelonephritis II: Diagnostic Studies and Management
Chronic Kidney Disease III: Interprofessional Care
Urine Studies II: Urine Culture and Sensitivity Test
Chronic Kidney Disease I: Introduction
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

